STOCK TITAN

Orbis and Allan Gray report 8.9% stake in Praxis Precision Medicines (PRAX)

(Moderate)
(Neutral)
Form Type
SCHEDULE 13G/A

Rhea-AI Filing Summary

Praxis Precision Medicines, Inc. ownership update: two institutional investors filed an amendment reporting combined beneficial ownership of 2,472,480 shares, representing 8.9% of common stock. The filing lists sole voting and dispositive power of 2,468,413 shares for Orbis Investment Management Ltd and 4,067 shares for Allan Gray Australia Pty Ltd.

The filing classifies both reporting persons as non‑U.S. institutions equivalent to an investment adviser and disclaims group beneficial ownership between them. Signatures certify comparability of foreign regulatory schemes and willingness to furnish Schedule 13D information if requested.

Positive

  • None.

Negative

  • None.

Insights

Two institutions hold a reported 8.9% stake in Praxis.

The filing states combined beneficial ownership of 2,472,480 shares, with Orbis holding 2,468,413 shares of sole voting and dispositive power and Allan Gray Australia holding 4,067 shares. This is a snapshot of disclosed positions, not an offer or transfer.

Future disclosures may clarify whether these holdings change; any material change would appear in subsequent ownership filings.

Submission follows Schedule 13G/A conventions for passive institutional investors.

The amendment classifies both filers as a Non‑U.S. Institution equivalent to an Investment Adviser and includes a certification about comparable foreign regulation. The filing disclaims group status and accepts staff requests for Schedule 13D information.

Read literally: the document documents ownership and regulatory equivalence; it does not state intent to act as a group or change voting arrangements.

Combined beneficial ownership 2,472,480 shares Amount beneficially owned as reported
Reported ownership percentage 8.9% Percent of class as reported
Orbis sole voting/dispositive power 2,468,413 shares Sole voting and dispositive power for Orbis Investment Management Ltd
Allan Gray sole voting/dispositive power 4,067 shares Sole voting and dispositive power for Allan Gray Australia Pty Ltd
Schedule 13G/A regulatory
"Amendment No. 1 and schedule header referencing beneficial ownership"
A Schedule 13G/A is an amended public filing with the U.S. securities regulator that updates a previous Schedule 13G, disclosing when an individual or group holds a substantial (typically over 5%) stake in a company and is claiming a passive, non‑controlling intent. Investors monitor these updates because rising or falling holdings can signal changing confidence, potential future moves, or shifts in voting power — like watching a public ledger where large shareholders quietly adjust their positions.
beneficial ownership financial
"Item 4. | Ownership (a) | Amount beneficially owned: 2,472,480"
Beneficial ownership means the person or entity that actually enjoys the benefits of owning shares or other assets — such as receiving dividends, voting rights, or price gains — even if the legal title is held in another name. For investors it matters because knowing who truly controls and profits from a company reveals who can influence decisions, exposes potential conflicts of interest or hidden concentration of power, and affects transparency and risk in the stock.
sole dispositive power regulatory
"Item 4. (iii) Sole power to dispose or to direct the disposition: Orbis - 2,468,413"
Sole dispositive power is the exclusive legal authority to decide what happens to a security — for example, whether to sell, transfer, or retain shares — without needing anyone else’s permission. Investors care because it signals who truly controls the economic outcome of an investment: like holding the only key to a safe, the holder can realize gains or losses and may trigger regulatory reporting, insider rules, or influence over corporate ownership.
Non‑U.S. Institution (FI) equivalent to an Investment Adviser (IA) regulatory
"Orbis Investment Management Ltd and Allan Gray Australia Pty Ltd are classified as a Non-U.S. Institution (FI)"

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates

FAQ

What stake does Orbis and Allan Gray report in PRAX?

Orbis Investment Management Ltd and Allan Gray Australia report combined beneficial ownership of 2,472,480 shares, equal to 8.9% of the outstanding common stock, with Orbis holding 2,468,413 shares and Allan Gray 4,067 shares.

Do the filers claim they act as a group in this 13G/A for PRAX?

No. The filing explicitly states that, although the Reporting Persons filed together, none represents it is a member of a group for purposes of Section 13(d)(3), and each disclaims beneficial ownership of the other's shares.

What voting and dispositive powers are reported by the filers?

The filing shows Orbis has sole voting and sole dispositive power over 2,468,413 shares; Allan Gray Australia has sole voting and dispositive power over 4,067 shares. Shared powers are reported as 0 for both.

What regulatory statement do the reporting persons include in the filing?

They certify that their foreign regulatory scheme is substantially comparable to the U.S. equivalent and undertake to furnish, upon request, information that would otherwise be disclosed in a Schedule 13D.





74006W207

(CUSIP Number)
03/31/2026

(Date of Event Which Requires Filing of this Statement)


Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)




schemaVersion:


SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G



ORBIS INVESTMENT MANAGEMENT LTD
Signature:Matthew Gaarder
Name/Title:Attorney-in-Fact
Date:05/15/2026
Allan Gray Australia Pty Ltd
Signature:Matthew Gaarder
Name/Title:Attorney-in-Fact
Date:05/15/2026